Dr Cheryl Barton

Freelance Journalist

Dr Barton is a freelance journalist specializing in the pharma and biotech sector.

Refine Search

Latest from Dr Cheryl Barton

Pharmaceutical

Oncology continues to drive M&A and dealmaking activity

An analysis of how - and why - oncology remains the hottest area for big-money deals in pharma. 1 July 2022

Pharmaceutical

AI attracting investor attention

Investment in artificial intelligence (AI) is on the increase in the pharma industry due to its capacity to drive efficiencies and innovation. 1 June 2022

Pharmaceutical

Sanofi M&A activity: what, when and why?

An in-depth look at the French drugmaker's movements on the deal-making front. 3 May 2022

Pharmaceutical

Why are SPACs of interest to pharma and biotech?

An overview of a trend that may - or may not - be here to stay in the biopharmaceutical sector. 1 April 2022

Biotechnology

The race is on for coronavirus vaccines and treatments: current R&D status

Since the first reports of coronavirus (COVID-19) in Wuhan, China in December 2019 there have been more than 823,000 confirmed cases and over 45,000 deaths in 206 countries worldwide. 1 April 2020

Pharmaceutical

Annual revenue of top 10 big pharma companies

According to market research, the worldwide pharmaceutical market was worth nearly $1.3 trillion in 2019 and the top 10 pharma companies accounted for around a third of sales ($392.5 billion). 3 March 2020

Pharmaceutical

The rationale behind Lilly's $1.1 billion takeover of Dermira

A look at why US drugmaker Eli Lilly is willing to spend more than $1 billion on the takeover of dermatology specialist Dermira. 11 February 2020

Pharmaceutical

Top ten quarterly M&A spenders, Q4 2019

Looking at the deals announced in the fourth quarter of 2019, the M&A landscape was dominated by large pharma but increasingly biopharma companies and generic manufacturers are expanding their product portfolios and services through M&A activities, too. 30 January 2020

Previous page 12

Dr Cheryl Barton

Today's issue

Latest from Dr Cheryl Barton

Company Spotlight